Michael Rudolph to Cetuximab
This is a "connection" page, showing publications Michael Rudolph has written about Cetuximab.
Connection Strength
0.043
-
PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models. Clin Cancer Res. 2020 06 15; 26(12):3058-3070.
Score: 0.043